How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?

Towse, Adrian; Chalkidou, Kalipso; Firth, Isobel; Kettler, Hannah; Silverman, Rachel

Towse, Adrian; Chalkidou, Kalipso; Firth, Isobel; Kettler, Hannah; Silverman, Rachel.

Affiliation

Towse A; Office of Health Economics, London, England, UK. Electronic address: atowse@ohe.org.
Chalkidou K; Center for Global Development, London, England, UK; Imperial College, London, England, UK.
Firth I; Office of Health Economics, London, England, UK.
Kettler H; PATH, Seattle, WA, USA.
Silverman R; Center for Global Development, London, England, UK.

Value Health ; 24(5): 625-631, 2021 05.

Article in En | MEDLINE | ID: mdl-33933230

Subject(s)

COVID-19/prevention & control; Global Health/economics; Immunization Programs/economics; COVID-19/economics; COVID-19 Vaccines/economics; COVID-19 Vaccines/therapeutic use; Civil Defense/methods; Civil Defense/trends; Economic Competition/standards; Economic Competition/trends; Global Health/trends; Humans; Immunization Programs/methods; COVID-19 Drug Treatment

Key words

Advance Market Commitment; COVID-19; global health; vaccines; value-based pricing

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Global Health / Immunization Programs / COVID-19 Type of study: Health_technology_assessment Limits: Humans Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google